Venous Insufficiency Treatment & Management

  • Author: Robert Weiss, MD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: May 26, 2011
 

Medical Care

Venous insufficiency is neither uncommon nor benign. Treatment is aimed at ameliorating the symptoms and, whenever possible, at correcting the underlying abnormality. Deep system disease is often refractory to treatment, but superficial system disease can usually be treated by ablating the refluxing vessels. Refluxing superficial vessels can safely be removed or ablated without sequelae; an incompetent vessel has already proved itself unnecessary because it is carrying venous blood in a retrograde direction.

Graduated compression is the cornerstone of the modern treatment of venous insufficiency. Properly fitted gradient compression stockings provide 30-40 or 40-50 mm Hg of compression at the ankle, with gradually decreasing compression at more proximal levels of the leg. This amount of gradient compression is sufficient to restore normal venous flow patterns in many or most patients with superficial venous reflux and to improve venous flow, even in patients with severe deep venous incompetence.

The compression gradient is extremely important because nongradient stockings or high-stretch elastic bandages (eg, ACE wraps) may cause a tourniquet effect, with worsening of the venous insufficiency. The so-called antiembolic stockings that are commonly available in American hospitals do not provide sufficient compression to improve the venous return from the legs, and they are not particularly effective in preventing venous thromboembolism. No patient with symptoms due to venous insufficiency should be without gradient compression hose, which can be prescribed by any physician. The prescription should specify one pair of gradient compression hose with a 30-40-mm Hg gradient that is calf-high (or thigh-high with waist attachment or panty hose style), with refills as needed.

All methods of venoablation are effective. Once the overall volume of venous reflux is reduced below a critical threshold by any mechanism, venous ulcerations heal, and patient symptoms are resolved.[5, 6]

  • Deep vein valvular incompetence is difficult to treat. Valvuloplasty is occasionally successful, but the incidence of postoperative DVT is high. Venous bypass is successful in select patients. External vein valve banding devices (eg, Venocuff device) and thermally induced collagen shrinkage procedures (eg, Closure procedure) are being investigated in clinical trials. At this time, the restoration of valvular function to incompetent deep veins remains an important focus of research for vascular physicians.
  • Patients with varicose bleeding usually present to an emergency department, where the traditional management is to oversew the involved vessel. Patients who have had significant blood loss may be admitted to the hospital, particularly if the bleeding varicosity is large and if the overlying tissue is friable. Oversewing a vessel almost always results in short-term control, but it can also cause the short-term recurrence of hemorrhage because the procedure does nothing to ablate the dilated, superficial, thin-walled vessel that has ruptured.
  • Variceal hemorrhage is best managed by means of primary sclerotherapy with sodium tetradecyl sulfate (Sotradecol). Tretbar reported a series of cases that were successfully treated by means of primary compression sclerotherapy over a 3-year period.[7] Sclerotherapy is performed by injecting or infusing a sclerosing substance into the refluxing vessel to produce endothelial destruction and fibrosis of the treated vessel.
  • Endovenous laser therapy (EVT) has been shown to have excellent results (>5 y) and a low rate of complications, which vary with the laser wavelength used. EVT is performed by passing a laser fiber from the knee to the groin and then delivering laser energy along the entire course of the vein. Destruction of the vascular wall is followed by fibrosis of the treated vessel.
  • Radiofrequency ablation (RFA) has been show to be effective, with a low rate of complications. It has produced excellent results that have been confirmed with up to 10 years of follow-up. RFA is performed by passing a special radiofrequency (RF) catheter from the knee to the groin and by controlled and preset heating of the targeted vessel until thermal injury causes shrinkage. The process is repeated every 7 centimeters along the course of the vein. Initial thermal injury is followed by fibrosis of the treated vessel.
  • Antibiotics rarely are useful in patients with venous ulcerations.
Next

Surgical Care

The primary goal of surgical therapy is to improve the venous circulation by correcting venous insufficiency by removing the major reflux pathways.

Traditional mechanisms of venoablation include ligation with stripping, simple ligation and division, sclerotherapy (with or without ligation), and stab avulsion (with or without ligation). These techniques offer roughly equivalent rates of technical success (although some disagreement exists between the medical and the surgical literature as to the prevalence and timing of varicose recurrences). Two newer methods of venoablation include RFA and EVLT.[8]

For superficial vein treatment, primary surgery offers a lower rate of early recurrence, whereas sclerotherapy produces fewer complications and offers higher rates of patient satisfaction both early and at follow-up. The relatively higher incidence of complications associated with surgery is offset by the relatively lower likelihood of early recurrence.[9, 10] As yet, no treatment for deep venous insufficiency has been proven both safe and effective. All current surgical procedures are experimental, or they have a low success rate and a high complication rate.

  • Vein stripping with ligation of the saphenofemoral junction was the most common surgical approach in cases of superficial venous insufficiency but has been replaced by endovenous ablation techniques such as RF and laser.
  • Simple ligation and division of the incompetent vessels is not an effective way to treat failed perforating vessels, because this procedure is associated with a high incidence of the early recurrence of reflux when it is applied to the great saphenous vein.
  • Skin grafts do not survive long unless the venous insufficiency has been treated, and after the venous insufficiency is ablated, the ulcer usually heals quickly, even without grafting.
Previous
Next

Consultations

Consultation with a phlebologist (a physician or vascular surgeon specializing in venous diseases) often yields new options for patients with chronic and seemingly refractory disease. Venous insufficiency syndromes can be diagnosed and treated by means of a variety of specialized techniques with which a generalist may not be familiar.

Previous
Next

Activity

Regular activity is an important ameliorating factor in patients with early or mild venous insufficiency syndrome. Patients with advanced disease do not tolerate activity well.

  • Prolonged standing or sitting can aggravate the symptoms of venous insufficiency.
  • Walking or running, bicycling, and swimming are excellent activities for patients with an intact and functioning calf muscle pump.
  • Patients with obstructed venous outflow usually experience increased pain and swelling with activity.
  • Patients with muscle pump failure usually have a markedly reduced exercise tolerance because of early leg fatigue.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Robert Weiss, MD  Associate Professor, Department of Dermatology, Johns Hopkins University School of Medicine

Robert Weiss, MD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American College of Phlebology, American Dermatological Association, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, and MedChi

Disclosure: Angiodynamics Honoraria Speaking and teaching; CoolTouch Corp Intellectual property rights Consulting; Cynosure Grant/research funds Independent contractor; Palomar Grant/research funds Independent contractor

Coauthor(s)

Craig F Feied, MD, FACEP, FAAEM, FACPh  Professor of Emergency Medicine, Georgetown University School of Medicine; General Manager, Microsoft Enterprise Health Solutions Group

Craig F Feied, MD, FACEP, FAAEM, FACPh is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Phlebology, American College of Physicians, American Medical Association, American Medical Informatics Association, American Venous Forum, Medical Society of the District of Columbia, Society for Academic Emergency Medicine, and Undersea and Hyperbaric Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

R Stan Taylor, MD  The JB Howell Professor in Melanoma Education and Detection, Departments of Dermatology and Plastic Surgery, Director, Skin Surgery and Oncology Clinic, University of Texas Southwestern Medical Center

R Stan Taylor, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Surgery, American Dermatological Association, American Medical Association, American Society for Dermatologic Surgery, Christian Medical & Dental Society, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Michael J Wells, MD  Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Mary Farley, MD  Dermatologic Surgeon/Mohs Surgeon, Anne Arundel Surgery Center

Disclosure: Nothing to disclose.

Glen H Crawford, MD  Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital

Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Department of Dermatology, Geisinger Medical Center

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References
  1. Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. Oct 1973;48(4):839-46. [Medline].

  2. Racette S, Sauvageau A. Unusual sudden death: two case reports of hemorrhage by rupture of varicose veins. Am J Forensic Med Pathol. Sep 2005;26(3):294-6. [Medline].

  3. Chiesa R, Marone EM, Limoni C, Volonte M, Schaefer E, Petrini O. Chronic venous insufficiency in Italy: the 24-cities cohort study. Eur J Vasc Endovasc Surg. Oct 2005;30(4):422-9. [Medline].

  4. Bonnetblanc JM. Leg ulcerations: a clinical appraisal. Eur J Dermatol. May-Jun 2005;15(3):127-32. [Medline].

  5. Zimmet SE. Venous leg ulcers: modern evaluation and management. Dermatol Surg. Mar 1999;25(3):236-41. [Medline].

  6. Sadick NS. Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure. Dermatol Clin. Jul 2005;23(3):443-55, vi. [Medline].

  7. Tretbar LL. Treatment of small bleeding varicose veins with injection sclerotherapy. Bleeding blue blebs. Dermatol Surg. Jan 1996;22(1):78-80. [Medline].

  8. Nijsten T, van den Bos RR, Goldman MP, et al. Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol. Jan 2009;60(1):110-9. [Medline].

  9. Nael R, Rathbun S. Treatment of varicose veins. Curr Treat Options Cardiovasc Med. Apr 2009;11(2):91-103. [Medline].

  10. Leopardi D, Hoggan BL, Fitridge RA, Woodruff PW, Maddern GJ. Systematic review of treatments for varicose veins. Ann Vasc Surg. Mar 2009;23(2):264-76. [Medline].

  11. Abbade LP, Lastoria S, Rollo Hde A. Venous ulcer: clinical characteristics and risk factors. Int J Dermatol. Apr 2011;50(4):405-11. [Medline].

  12. Diehm C, Allenberg JR. Color Atlas of Vascular Diseases. New York, NY: Springer Publishing; 1999:1-396.

  13. Feied CF. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Semin Dermatol. Jun 1993;12(2):135-49. [Medline].

  14. Feied CF. Peripheral venous disease. In: Rosen and Barkin, eds. Emergency Medicine Principles and Practice. Vol 3. 4th ed. St. Louis, Mo: Mosby-Year Book; 1998:Chapter 107.

  15. Goldman MP. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 2nd ed. St. Louis, Mo: Mosby-Year Book; 1995:1-519.

  16. Weiss RA, Feied CF, Weiss MA. Vein Diagnosis & Treatment: A Comprehensive Approach. New York, NY: McGraw-Hill; 2001:1-304.

Previous
Next
 
Superficial venous insufficiency with skin changes.
Ulcer due to venous insufficiency.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.